Fasting for Type 1 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how fasting affects blood sugar control in people with type 1 diabetes, particularly during episodes of low blood sugar. Researchers seek to determine if fasting alters the body's response to insulin, which is crucial for diabetes management. Participants will be divided into two groups: one will fast, and the other will consume regular meals before testing. Individuals with type 1 diabetes who are not obese and are C-peptide negative (indicating no insulin production) may be suitable candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to scientific knowledge and potentially enhance diabetes management strategies.
Do I need to stop my current medications for the trial?
You may need to stop certain medications, especially if you are taking steroids for inflammation or medications that affect adrenergic signaling, like beta-blockers or bronchodilators. The trial does not specify other medications, so it's best to discuss your current medications with the study team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that fasting can be safe for people with type 1 diabetes. Some studies suggest that fasting might reduce the need for insulin, benefiting diabetes management. One study found that different fasting methods, such as intermittent fasting, can be safe and effective for weight loss in people with type 1 diabetes. This indicates that fasting might aid in weight management and be well-tolerated.
In this trial, researchers are comparing fasting with regular meals to assess their effects on blood sugar control. Although past research is promising, consulting a healthcare provider before altering a diabetes management plan is crucial.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how fasting and feeding affect blood sugar management in people with Type 1 diabetes. Unlike traditional approaches that rely heavily on insulin therapy and careful monitoring, this trial looks at how meal timing and fasting might play a role in preventing hypoglycemia, a common and dangerous complication. By comparing fasting with normal eating patterns before insulin administration, they hope to uncover new insights into how diet can impact diabetes management and potentially open up new avenues for less medication-dependent strategies.
What evidence suggests that this trial's treatments could be effective for type 1 diabetes?
This trial will compare the effects of fasting and feeding in individuals with type 1 diabetes. Research has shown that fasting can benefit people with type 1 diabetes. Studies have found that fasting may reduce the need for extra insulin, the primary treatment for diabetes. In some cases, fasting also helps lower blood sugar levels and body weight. Maintaining stable blood sugar levels is crucial for managing diabetes. Although more research is needed, these findings suggest that fasting might help control diabetes.15678
Are You a Good Fit for This Trial?
This trial is for non-obese individuals with type 1 diabetes, who have a C-peptide negative status. It's open to all genders and ethnicities, provided they don't smoke or have complications like neuropathy, retinopathy, nephropathy, HIV/hepatitis, cardiovascular diseases or are on certain medications like steroids or beta-blockers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Trial 1: Feeding
Participants eat an isocaloric breakfast and lunch prior to an insulin-induced hypoglycemic challenge
Trial 2: Fasting
Participants remain fasted prior to an insulin-induced hypoglycemic challenge
Follow-up
Participants are monitored for safety and effectiveness after the hypoglycemic challenges
What Are the Treatments Tested in This Trial?
Interventions
- Fasting
- Feeding
Trial Overview
The study investigates how fasting affects the body's response to low blood sugar in people with type 1 diabetes. Participants will undergo periods of fasting and feeding to see how these states influence their hormonal and liver responses during insulin-induced hypoglycemia.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Subjects will eat a normal breakfast and lunch prior to insulin-induced hypoglycemia.
Subjects will remain fasted prior to insulin-induced hypoglycemia.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Cincinnati
Lead Sponsor
Citations
Efficacy of Fasting in Type 1 and Type 2 Diabetes Mellitus
Published research assessing the effect of fasting in T1DM has demonstrated positive outcomes, including a reduced need for exogenous insulin [8] ...
Intermittent fasting versus continuous caloric restriction for ...
IF shown substantial short-term advantages, encompassing marked decreases in HbA1c levels, fasting glucose, and body weight. Mechanistic discoveries emphasized ...
Intermittent fasting strategies and their effects on body ...
The current evidence provides some indication that intermittent fasting diets have similar benefits to continuous energy restriction for weight loss and ...
A 5:2 Intermittent Fasting Meal Replacement Diet and ...
In this randomized clinical trial of 405 adults, the 5:2 MR approach achieved better glycemic control at 16 weeks compared with metformin and empagliflozin.
The effects of different intermittent fasting regimens in ...
The SUCRA results showed that patients with T2DM on TWF had the best combined effect in improving fasting glucose and insulin resistance ...
The safety and efficacy of weight loss via intermittent ...
These findings suggest that both intermittent fasting or continuous energy restriction are safe and effective weight loss approaches for people with type 1 ...
Effect of Intermittent Compared With Continuous Energy ...
Intermittent energy restriction is safe for people who have either diet-controlled type 2 diabetes or are using medication that is not likely to ...
Review Clinical potential of fasting in type 1 diabetes
This review examines the efficacy of TRE and other fasting protocols in improving weight and glycemic control in patients with obesity and T1DM.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.